You are here

  • Home
  • Archive
  • Volume 79, Issue Suppl 1
  • THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Thursday, 04 June 2020
Rheumatoid arthritis - non biologic treatment and small molecules
THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 20209806
Jul 20207805
Aug 202012603
Sep 2020232016
Oct 202022608
Nov 2020255014
Dec 2020212015
Jan 2021177012
Feb 202119806
Mar 2021267022
Apr 2021262022
May 20219008
Jun 20218014
Jul 20217013
Aug 2021609
Sep 20216012
Oct 202112407
Nov 2021152012
Dec 20217406
Jan 20228604
Feb 2022111011
Mar 202218107
Apr 202215106
May 202216806
Jun 20224502
Jul 20225302
Aug 202210102
Sep 20227403
Oct 20229303
Nov 202217008
Dec 20224900
Jan 20233503
Feb 20232201
Mar 20236302
Apr 20234700
May 20237003
Jun 20234305
Jul 202311103
Aug 20232301
Sep 20234600
Oct 20234003
Nov 20234801
Dec 20231802
Jan 20244503
Feb 20242401
Mar 20243002
Total45450294